Global biopharmaceuticals manufacturer AstraZeneca has committed $200 million to the company’s facility in North Ryde, Sydney. The investment will go towards increasing the facility’s production capabilities, creating 250 jobs and increasing exports to $4.4 billion over the next four years. The investment is in addition to the $100 million announced in 2017. Chief executive officer, … Continue reading AstraZeneca invests $200m in local manufacturing capability
While conditions in the Australian manufacturing industry remain challenging amid weakness in the global economy, there are certain companies that are bucking the trend and taking advantage of strong opportunities for growth.
Australia’s car industry is faltering and our wine sector is facing increasing offshore competition, however, there is good news when it comes to pharmaceutical manufacturers, Alex Heber reports.